Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Clinical trial NCT00595309 · COMPLETED

Trial details

NCT number: NCT00595309
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2007-12-01
Primary completion: 2009-10-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.